Rashmi P. Sharma
Research Subjects
Rashmi P. Sharma has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Rajaram Sakharam Mane
Swami Ramanand Teerth Marathwada University
5 shared publications - Siddheshwar Dadarao Raut
Department of Future Energy Convergence, Seoul National University of Science & Technology, 232 Gongneung-Ro, Nowon-Gu, Seoul 01811, Republic of Korea
4 shared publications Ambadas S. Kadam
Department of Botany, DSM’S ACS, College, Jintur, India
3 shared publicationsRamjan M. Mulani
School of Life Sciences, Swami Ramanand Teerth Marathwada University, Nanded, India
3 shared publications- Aditya Abha Singh
Department of Botany, University of Lucknow, Lucknow, 226007 India
1 shared publication - Ajit Kumar
Toxicology and Computational Biology Group, Centre for Bioinformatics, Maharshi Dayanand University, Rohtak, India
1 shared publication
Latest Publications
- Open Access
- 20 August 2026
- Published by Termedia Sp. z.o.o. in BioTechnologia
Cytotoxic plants from the Indian subcontinent: promising reservoir of anticancer agents
In recent decades, cancer has remained the leading cause of mortality globally. The increasing incidence of cancer and the rise in the mortality rate pose substantial challenges for effective management strategies. Currently, several chemotherapeutic agents, including cisplatin, doxorubicin, and gemcitabine, are routinely used as frontline treatment options for cancer. Although these agents exhibit initial efficacy during the early stages of tumor development, their widespread application in clinical settings is significantly limited by their lack of selectivity, high cost, and toxicity to normal tissues. Phytochemicals have been recognized as promising alternatives to address these limitations. Their remarkable anticancer efficacy is attributed to various distinct mechanisms. Additionally, they are cost-effective and relatively nontoxic, which represent a significant advantage over conventional treatment approaches. To date, only a few phytochemicals, including resveratrol, gingerol, curcumin, and epigallocatechin-3-gallate, have progressed to clinical application. However, the current array of these phytochemicals is inadequate to meet the increasing demand for novel medicines against cancer. Thus, ethnopharmacology has emerged as a promising avenue for discovering and developing novel anticancer drugs. Medicinal plants from the Indian subcontinent are a valuable resource of diverse phytochemicals, which have traditionally been used for treating several health conditions and diseases. However, the evaluation of potential of these phytochemicals as anticancer medicines has largely been limited to preliminary screening. Therefore, this review specifically explores potent anticancer plants native to the Indian subcontinent that are yet to undergo rigorous clinical validation. It includes 60 plants from 44 families and details their therapeutic targets in various malignant cancers. It also discusses the major challenges and potential prospects for their effective application in cancer treatment.
- 20 August 2026
- Published by Termedia Sp. z.o.o. in BioTechnologia
Open AccessCytotoxic plants from the Indian subcontinent: promising reservoir of anticancer agents
In recent decades, cancer has remained the leading cause of mortality globally. The increasing incidence of cancer and the rise in the mortality rate pose substantial challenges for effective management strategies. Currently, several chemotherapeutic agents, including cisplatin, doxorubicin, and gemcitabine, are routinely used as frontline treatment options for cancer. Although these agents exhibit initial efficacy during the early stages of tumor development, their widespread application in clinical settings is significantly limited by their lack of selectivity, high cost, and toxicity to normal tissues. Phytochemicals have been recognized as promising alternatives to address these limitations. Their remarkable anticancer efficacy is attributed to various distinct mechanisms. Additionally, they are cost-effective and relatively nontoxic, which represent a significant advantage over conventional treatment approaches. To date, only a few phytochemicals, including resveratrol, gingerol, curcumin, and epigallocatechin-3-gallate, have progressed to clinical application. However, the current array of these phytochemicals is inadequate to meet the increasing demand for novel medicines against cancer. Thus, ethnopharmacology has emerged as a promising avenue for discovering and developing novel anticancer drugs. Medicinal plants from the Indian subcontinent are a valuable resource of diverse phytochemicals, which have traditionally been used for treating several health conditions and diseases. However, the evaluation of potential of these phytochemicals as anticancer medicines has largely been limited to preliminary screening. Therefore, this review specifically explores potent anticancer plants native to the Indian subcontinent that are yet to undergo rigorous clinical validation. It includes 60 plants from 44 families and details their therapeutic targets in various malignant cancers. It also discusses the major challenges and potential prospects for their effective application in cancer treatment.
- 25 April 2026
- Published by World Scientific Pub Co Pte Ltd in Journal of Computational Biophysics and Chemistry
- p. 1-22
Discovery of Novel KRAS Inhibitors: A Computational Study
- 25 April 2026
- Published by World Scientific Pub Co Pte Ltd in Journal of Computational Biophysics and Chemistry
- p. 1-22
Discovery of Novel KRAS Inhibitors: A Computational Study
- 19 May 2023
- Published by Springer Nature
- p. 137-171
Nano-antimicrobial Materials: Alternative Antimicrobial Approach
- 19 May 2023
- Published by Springer Nature
- p. 137-171
Nano-antimicrobial Materials: Alternative Antimicrobial Approach
- 19 May 2023
- Published by Springer Nature
- p. 101-135
Surface-Modified Nanomaterials for Biogenic Applications
- 19 May 2023
- Published by Springer Nature
- p. 101-135
Surface-Modified Nanomaterials for Biogenic Applications
- 25 April 2022
- Published by Springer Nature in Folia Microbiologica
- Vol. 67 (5) , 747-755
Assessment of antibacterial and anti-biofilm effects of zinc ferrite nanoparticles against Klebsiella pneumoniae
In response to the emergence of drug resistance and limited therapeutic options, researchers are in action to look for more effective and sustainable antimicrobial practices. Over few years, novel nanoparticles are proving to be potent and promising for effectively dealing with ever- evolving microbial pathogens and diseases. In the present investigation, antibacterial and anti-biofilm efficiencies of zinc ferrite nanoparticles (ZnFe2O4 NPs) are explored against opportunistic pathogens Klebsiella pneumoniae (K. pneumoniae). Results of the present study demonstrate that the ZnFe2O4 NPs endow an excellent antibacterial efficiency with a maximum zone of inhibition i.e.16 mm. The reactive oxygen species (ROS)-induced bacterial damage is caused by the ZnFe2O4 NPs. Subsequently, intracellular cytoplasmic leakage of sugar and protein confirms their ability to disturb the membrane integrity of bacteria. This study also demonstrates the prominent efficiency of ZnFe2O4 NPs in an anti-biofilm study by inhibiting biofilm formation up to 81.76% and reducing mature biofilm up to 56.22% at 75 μg/mL the minimum inhibitory concentration value. Therapeutic possibilities of the ZnFe2O4 NPs in antimicrobial applications are discussed which are helpful to overcome the challenges associated with biofilm infectivity.
- 25 April 2022
- Published by Springer Nature in Folia Microbiologica
- Vol. 67 (5) , 747-755
Assessment of antibacterial and anti-biofilm effects of zinc ferrite nanoparticles against Klebsiella pneumoniae
In response to the emergence of drug resistance and limited therapeutic options, researchers are in action to look for more effective and sustainable antimicrobial practices. Over few years, novel nanoparticles are proving to be potent and promising for effectively dealing with ever- evolving microbial pathogens and diseases. In the present investigation, antibacterial and anti-biofilm efficiencies of zinc ferrite nanoparticles (ZnFe2O4 NPs) are explored against opportunistic pathogens Klebsiella pneumoniae (K. pneumoniae). Results of the present study demonstrate that the ZnFe2O4 NPs endow an excellent antibacterial efficiency with a maximum zone of inhibition i.e.16 mm. The reactive oxygen species (ROS)-induced bacterial damage is caused by the ZnFe2O4 NPs. Subsequently, intracellular cytoplasmic leakage of sugar and protein confirms their ability to disturb the membrane integrity of bacteria. This study also demonstrates the prominent efficiency of ZnFe2O4 NPs in an anti-biofilm study by inhibiting biofilm formation up to 81.76% and reducing mature biofilm up to 56.22% at 75 μg/mL the minimum inhibitory concentration value. Therapeutic possibilities of the ZnFe2O4 NPs in antimicrobial applications are discussed which are helpful to overcome the challenges associated with biofilm infectivity.
- 30 September 2020
- Published by Springer Nature in Applied Physics A
- Vol. 126 (10) , 1-9
In-vitro antibacterial and anti-biofilm efficiencies of chitosan-encapsulated zinc ferrite nanoparticles
- 30 September 2020
- Published by Springer Nature in Applied Physics A
- Vol. 126 (10) , 1-9
In-vitro antibacterial and anti-biofilm efficiencies of chitosan-encapsulated zinc ferrite nanoparticles
- Open Access
- 14 March 2019
- Published by Springer Nature in International Nano Letters
- Vol. 9 (2) , 141-147
Sol–gel auto-combustion mediated cobalt ferrite nanoparticles: a potential material for antimicrobial applications
- 14 March 2019
- Published by Springer Nature in International Nano Letters
- Vol. 9 (2) , 141-147
Open AccessSol–gel auto-combustion mediated cobalt ferrite nanoparticles: a potential material for antimicrobial applications
- 13 November 2018
- Published by Elsevier in Materials Letters
- Vol. 237, 165-167
Anti-candida and anti-adhesion efficiencies of zinc ferrite nanoparticles
- 13 November 2018
- Published by Elsevier in Materials Letters
- Vol. 237, 165-167
Anti-candida and anti-adhesion efficiencies of zinc ferrite nanoparticles